These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22144219)

  • 1. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
    Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z
    Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
    Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B
    Swiss Med Wkly; 2005 Sep; 135(37-38):549-54. PubMed ID: 16333765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.
    Schultz M; Faber J; Kistorp C; Jarløv A; Pedersen F; Wiinberg N; Hildebrandt P
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):54-9. PubMed ID: 14678288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.
    Ozmen B; Ozmen D; Parildar Z; Mutaf I; Bayindir O
    Endocr Res; 2007; 32(1-2):1-8. PubMed ID: 18271501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism.
    Ertugrul DT; Gursoy A; Sahin M; Unal AD; Pamuk B; Berberoglu Z; Ayturk S; Tutuncu NB; Demirag NG
    J Natl Med Assoc; 2008 Apr; 100(4):401-5. PubMed ID: 18481478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations.
    Manuchehri AM; Jayagopal V; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2006 May; 43(Pt 3):184-8. PubMed ID: 16704752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
    Lerch M; Meier C; Staub JJ
    Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin and obestatin in thyroid dysfunction.
    Gurgul E; Ruchała M; Kosowicz J; Zamysłowska H; Wrotkowska E; Moczko J; Sowiński J
    Endokrynol Pol; 2012; 63(6):456-62. PubMed ID: 23339003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing thyroid disease in general practice.
    Walsh JP
    Med J Aust; 2016 Aug; 205(4):179-84. PubMed ID: 27510349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
    Díez JJ
    Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
    Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
    Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
    Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism.
    Kohno M; Murakawa K; Yasunari K; Nishizawa Y; Morii H; Takeda T
    Am J Med; 1987 Oct; 83(4):648-52. PubMed ID: 2960235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.
    Ozkaya M; Sahin M; Cakal E; Yuzbasioglu F; Sezer K; Kilinc M; Imrek SS
    J Endocrinol Invest; 2009 May; 32(5):435-9. PubMed ID: 19498324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
    Faber J; Wiinberg N; Schifter S; Mehlsen J
    Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.
    Bodlaj G; Pichler R; Brandstätter W; Hatzl-Griesenhofer M; Maschek W; Biesenbach G; Berg J
    Ann Med; 2007; 39(8):608-16. PubMed ID: 17852031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.